ArticleJournal of hepatocellular carcinoma2026
Predictive Modeling and Mendelian Randomization for Identifying HCC Patients with High Response to TACE with Atezolizumab and Bevacizumab.
Wenhao Chen et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.